Srinagar: The Directorate of Health Services, Kashmir (DHSK) launched a daily DOTS medicine course free of charge for newly detected tuberculosis patients across the Valley under Revised National Tuberculosis Control Programme (RNTCP).
Earlier, TB patients were being treated on intermittent DOTS regimen where patients were administered medicines three days a week.
Director of DHSK Saleem Ur Rehman launched the daily- based DOTS Regimen (medicine doses) at District Tuberculosis Centre, Srinagar where he distributed the medicines to newly detected TB patients, an official spokesperson said.
The event was organised by District TB Centre under the aegis of State TB Control Society and DHSK, he said.
On the occasion, Rehman said in India, around 600 people die of tuberculosis every day.
"But in the Valley, the cure rate is 85 percent compared to the rest of the country and DHSK is working very hard to improve the rate further," he said.
"The new treatment protocol replaces the existing three times a week treatment and will be implemented across Kashmir. Instead of several individual drugs, patients will be put on fixed drug combinations, that is three or more drugs as a single dose, to reduce the pill burden and to simplify the treatment," the director said.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!